Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 35440621
Lee SB, et al. (2022) Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription. Nat Commun 13, 2089 35440621
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S5-p - ID2 (human)
Modsite: ___MKAFsPVRSVRk SwissProt Entrez-Gene
Orthologous residues
ID2 (human): S5‑p, ID2 (mouse): S5‑p, ID2 (rat): S5‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  brain cancer, glioblastoma, glioma
Relevant cell lines - cell types - tissues:  HeLa (cervical), U-251MG (glioma)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE CDK1 (human)
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
dinaciclib decrease
palbociclib no change compared to control
Downstream Regulation
Effect of modification (function):  molecular association, regulation, protein stabilization, ubiquitination
Effect of modification (process):  cell cycle regulation, transcription, altered
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
APC (human) Disrupts pull-down assay, co-immunoprecipitation
Comments:  inhibits ubiquitination

S14-p - ID2 (human)
Modsite: VRSVRkNsLsDHSLG SwissProt Entrez-Gene
Orthologous residues
ID2 (human): S14‑p, ID2 (mouse): S14‑p, ID2 (rat): S14‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Cellular systems studied:  cell lines
Species studied:  human

T27-p - ID2 (human)
Modsite: LGISRSKtPVDDPMS SwissProt Entrez-Gene
Orthologous residues
ID2 (human): T27‑p, ID2 (mouse): T27‑p, ID2 (rat): T27‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Cellular systems studied:  cell lines
Species studied:  human